We are a mental health care company motivated by the need to find better ways to help and empower people suffering around the world. Our first major initiative is developing psilocybin therapy for treatment-resistant depression. Psilocybin is the active ingredient in so-called “magic mushrooms” and we are running the world’s first large-scale psilocybin therapy clinical trial, in Europe and North America. We are a team of leading experts in medicine, mental health, business, and academia, and we put patients at the heart of everything we do. We have put a lot of thought into the kind of organisation we want to be, and our whole team has worked together to articulate four core values that define us: compassion, innovation, trust, and collaboration.